Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Gnosa, Sebastian ^a   Shen, Yang Mei ^b   Wang, Chao Jie ^a   Zhang, Hong ^c   Stratmann, Johannes ^a   Arbman, Gunnar ^d   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF SKÖVDE   (Sweden)

^d VRINNEVI HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTE ELEVATED GENE 1 PROTEIN; BETA ACTIN; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; ONCOPROTEIN; PROTEIN P53; PROTEIN P73; RAD50 PROTEIN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; MTDH PROTEIN, HUMAN;

AGED; APOPTOSIS; ARTICLE; ASTROCYTE ELEVATED GENE 1; CANCER CELL CULTURE; CANCER STAGING; CELL NUCLEUS; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CYTOPLASM; DISEASE ASSOCIATION; DNA DAMAGE; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR LOCALIZATION; UPREGULATION; WESTERN BLOTTING; BIOLOGICAL MODEL; COLON TUMOR; GENETICS; INTESTINE MUCOSA; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

AGED; APOPTOSIS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL NUCLEUS; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM STAGING; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861470722     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-109     Document Type: Article

References (43)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 94:1132-1145.
2. Lynch HT, . de la Chapelle A Hereditary colorectal cancer. N Engl J Med 2003, 348:919-932. 10.1056/NEJMra012242, 12621137, de la Chapelle.
3. Giovannucci E, Willet WC. Dietary factors and risk of colon cancer. Ann Med 1994, 26:443-452. 10.3109/07853899409148367, 7695871.
4. Fearon ER, Vogelstein B. A genetic model of colorectal tumorgenesis. Cell 1990, 61:759-767. 10.1016/0092-8674(90)90186-I, 2188735.
5. Waldner MJ, Neurath MF. The molecular therapy of colorectal cancer. Mol Aspects Med 2010, 31:171-178. 10.1016/j.mam.2010.02.005, 20171980.
6. Su ZZ, Chen Y, Kang DC, Chao W, Simm M, Volsky DJ, Fisher PB. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene 2003, 30:67-78.
7. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004, 5:365-374. 10.1016/S1535-6108(04)00079-0, 15093543.
8. Yu C, Chen K, Zheng H, Guo X, Jai W, Li M, Zeng M, Li J, Song L. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009, 30:894-901. 10.1093/carcin/bgp064, 19304953.
9. Jian-bo X, Hui W, Yu-long H, Chang-hua Z, Long-juan Z, Shi-rong C, Wen-hua Z. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol 2011, 28:455-462. 10.1007/s12032-010-9475-6, 20300973.
10. Song H, Li C, Li R, Geng J. Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis 2010, 25:1201-1209. 10.1007/s00384-010-1009-3, 20625905.
11. Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet JM, Fisher PB, Sarkar D. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009, 119:465-477. 10.1172/JCI36460, 2648696, 19221438.
12. Song L, Li W, Zhang H, Liao W, Dai T, Yu C, Ding X, Zhang L, Li J. Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol 2009, 219:317-326. 10.1002/path.2595, 19644957.
13. Lee SG, Jeon HY, Su ZZ, Richards JE, Vozhilla N, Sarkar D, Van Maerken T, Fisher PB. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009, 28:2476-2484. 10.1038/onc.2009.93, 19448665.
14. Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, Li M. Astrocyte eleveated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008, 14:3319-3326. 10.1158/1078-0432.CCR-07-4054, 18519759.
15. Thirkettle HJ, Girling J, Warren AY, Mills IG, Sahadevan K, Leung H, Hamdy F, Whitaker HC, Neal DE. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin Cancer Res 2009, 15:3033-3313.
16. Chen W, Ke Z, Shi H, Yang S, Wang L. Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. Neoplasma 2010, 57:522-529. 10.4149/neo_2010_06_522, 20845990.
17. Sutherland HG, Lam YW, Biers S, Lamond AI, Bickmore WA. 3D3/lyric: a novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Exp Cell Res 2004, 300:134-148. 10.1016/j.yexcr.2004.06.026, 15383321.
18. Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB. Astrocye elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 2006, 103:17390-17305. 10.1073/pnas.0608386103, 1859939, 17088530.
19. Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K, Fisher PB. Activation of nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 2006, b 66:1509-1516.
20. Lewander A, Gao J, Carstensen J, Arbman G, Zhang H, Sun XF. NF-κB p65 phosphorylated at serine 536 is an independent prognostic factor in swedish colorectal cancer patients. Int J Colorectal Dis In press.
21. Sun XF, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T, Nordenskjöld B. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992, 340:1369-1373. 10.1016/0140-6736(92)92558-W, 1360088.
22. Sun XF. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res 2002, 8:165-170.
23. Gao J, Zhang H, Arbman G, Sun XF. The different roles of hRAD50 in microsatellite stable and unstable colorectal cancers. Dis Markers 2008, 24:127-134.
24. Evertsson S, Bartik Z, Zhang H, Jansson A, Sun XF. Apoptosis in relation to proliferating cell nuclear antigen and Dukes'stage in colorectal adenocarcinoma. Int J Oncol 1999, 15:53-58.
25. Morikawa K, Walker SM, Jessup M, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 1988, 48:1943-1948.
26. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup M, Fidler IJ. Influence or organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988, 48:6863-6871.
27. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005, 353:8-15. 10.1016/j.gene.2005.04.006, 15927426.
28. Liu X, Zhang N, Li X, Moran MS, Yuan C, Yan S, Jiang L, Ma T, Haffty BG, Yang O. Identification of novel variants of metadherin in breast cancer. PLoS One 2011, 6:e17582. 10.1371/journal.pone.0017582, 3050918, 21408129.
29. Norwood MG, Mann CD, Hemingway D, Miller AS. Colorectal cancer: presentation and outcome in British South Asians. Colorectal Dis 2009, 11:745-749. 10.1111/j.1463-1318.2008.01675.x, 19708093.
30. Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al-Mandhari M, AL-Mawaly K, Al-Mjeni R, AL-Sayegh A, Reaburn S, Lee E, Giardiello F, Smoot DT, Vilkin A, Boland CR, Goel A, Hafezi M, Nouraie M, Ashktorab H. Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol Cancer 2008, 7:68. 10.1186/1476-4598-7-68, 2551625, 18718023.
31. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG, Kang Y. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009, 15:9-20. 10.1016/j.ccr.2008.11.013, 2676231, 19111877.
32. Li FY, Lai MD. Colorectal cancer, one entity or three. J Zhejiang Univ Sci 2008, B 10:219-229.
33. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001, 195:171-178. 10.1002/path.918, 11592095.
34. Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Daidone MG, Leo E, Pilotti S, Bertario L, Pierotti MA. Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 2004, 10:4015-4021. 10.1158/1078-0432.CCR-04-0031, 15217933.
35. Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ, Fisher PB. Identification and cloning of human astrocyte genes displaying the elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 2002, 21:3592-3602. 10.1038/sj.onc.1205445, 12032861.
36. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2007, 27:1114-1121.
37. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M, Dahiya R. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007, 26:7647-7655. 10.1038/sj.onc.1210572, 17563745.
38. Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A, Doi T, Saiki I. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 2003, 278:36916-36923. 10.1074/jbc.M301598200, 12842894.
39. Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 2008, 68:1478-1484. 10.1158/0008-5472.CAN-07-6164, 18316612.
40. Martin AG, Trama J, Crighton D, Ryan KM, Fearnhead HO. Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B. Aging 2009, 1:335-349. 2830049, 20195489.
41. Su P, Zhang Q, Yang Q. Immunohistochemical analysis of Methadherin in proliferative and cancerous breast tissue. Diagn Pathol 2010, 5:38. 10.1186/1746-1596-5-38, 2906416, 20565850.
42. Soong R, Robbins PD, Dix BR, Grieu F, Lim B, Knowles S, Williams KE, Turbett GR, House AK, Iacopetta BJ. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum Pathol 1996, 27:1050-1055. 10.1016/S0046-8177(96)90282-8, 8892589.
43. Miyamoto S. Nuclear initiated NF-κB signaling: Nemo and ATM take center stage. Cell Res 2011, 21:116-130. 10.1038/cr.2010.179, 3193401, 21187855.